Español Català Italiano Deutsch Euskara Portugues Française Galego English

Tuesday, January 13, 2026

Updated Tuesday, January 13, 2026 at 07:54:27 PM

International technological cooperation in R&D and health

CDTI is looking for a Spanish partner to develop an artificial intelligence system for cancer research in Brazil, together with Diasci.

Newsroom Tuesday, December 09 of 2025 Reading time:

The Spanish innovation promotion agency is seeking a national technology company to collaborate with the Brazilian firm Diasci. The bilateral project aims to integrate AI models into clinical diagnostic sensors for cancer detection.

[Img # 65902]

 

El CDTI Innovation has begun the process of finding a Spanish company for a bilateral technology cooperation project with Brazil. The initiative, in collaboration with the company Diasci Scientific Diagnostics and Advanced Technological Solutions LTDA, pursues the development of a model of Artificial Intelligence applied to oncology under the framework of R&D cooperation between Spain and the State of São Paulo.

 

Project objective: Digitization of cancer diagnosis

 

 

 

The strategic collaboration between the future Spanish entity and the Brazilian company focuses on creating an advanced solution for the healthcare sector. DiasciA company specializing in medical devices for cancer detection and diagnosis requires a technology partner to evolve its current systems into a solution fully digital.

 

 

The core of the project consists of generating a model based on Artificial Intelligence capable of integrating into a Clinical Decision Support System (CDSS)This tool is specifically designed to assist oncologists in making critical decisions, increasing the accuracy and efficiency of medical diagnoses.

 

 

 

 

Technical integration and scope of innovation

 

 

 

The technical proposal combines proprietary hardware with new software developments. The technological workflow proposed by the CDTI Innovation and its Brazilian counterpart envisions the convergence of two main sources of information to feed the algorithm:

 

  • Biological data: Obtained through the sensor patented by Diasci.
  • AI Developments: Provided by the project to process biological information.
  • Final result: An integrated clinical decision support system for oncology specialists.

 

 

 

 

Call framework and key deadlines

 

 

 

This internationalization opportunity falls within the framework of the bilateral R&D cooperation program managed between the State of Sao Paulo and Spain. Below are the key details for Spanish companies interested in submitting their application or requesting more information from CDTI:

 

 

Charge Description Detail
Managing Body CDTI Innovation (Spain)
International Partner Diasci Scientific Diagnostics and Advanced Technological Solutions LTDA (Brazil)
Technological Field Health, Oncology and Artificial Intelligence
Next cut-off date March 31th 2026

 

 

 

 

Key points and frequently asked questions about the Spain-Brazil Bilateral Project

 

 

What exactly is the CDTI seeking with this call?
El CDTI Innovation is looking for a Spanish company capable of developing models of Artificial Intelligence to integrate them into a medical project together with the Brazilian company Diasci.

 

What is the technical purpose of the collaboration?
The goal is to create a Clinical Decision Support System (CDSS) for oncologists that combines data from biological sensors with AI algorithms, achieving a digital diagnosis.

 

 

When does the deadline for this initiative end?
The initiative is part of the cooperation program with the State of São Paulo, whose next administrative cut-off date is set for the March 31th 2026.

 

With your registered account

Write your email and we will send you a link to write a new password.